Powered Anastomosis Device Market Report 2026: Analyst-Verified Data & Forecast

Powered Anastomosis Device by Application (GI Surgeries, Cerebrovascular Disease), by Types (Non-absorbable Surgical Sutures, Absorbable Surgical Sutures), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $480 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $480 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Powered Anastomosis Device Market Overview

Powered anastomosis devices—electromechanical staplers that create rapid, leak-proof surgical connections—are rapidly becoming the standard of care in minimally invasive GI, bariatric and thoracic procedures. With the Powered Anastomosis Device market size surpassing USD 1.4 billion in 2024, the sector is on a robust growth outlook driven by rising intra-corporeal anastomoses, value-based procurement models, and the global shift toward robotic-assisted surgery. Our 2025–2033 market forecast calls for a high-single-digit CAGR, underpinning sustained industry expansion** as hospitals replace manual staplers with reloadable, battery-powered and single-use powered stapling systems.

Loading chart…

Three macro forces are re-shaping competitive dynamics: (1) technology shifts to AI-enabled stapling with real-time tissue feedback, (2) tightening FDA and EU safety regulations catalyzing premium-priced safety-engineered devices, and (3) hospital GPO consolidation that rewards vendors bundling staplers, energy devices and service contracts. North America commands the largest share (>40 %) on the back of high bariatric volumes and favorable reimbursement, while Asia-Pacific is the fastest-growing region as China and India accelerate adoption of robotic surgery platforms and bulk-procure powered staplers to manage large patient backlogs.

Report Overview

Report Attribute	Details
Market size value in 2025	480.00 million
Revenue forecast in 2033	1.22 billion
Growth rate	CAGR of 12.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	B. Braun Melsungen; Medtronic Plc; Johnson & Johnson; Smith & Nephew Plc; Intuitive Surgical Inc; Becton, Dickinson and Company; CONMED Corporation; Artivion, Inc.; Advanced Medical Solutions Group Plc; Baxter International, Inc.; Boston Scientific Corporation; Teleflex; DemeTECH Corporation; Meril Life Sciences; Péters Surgical; Purple Surgical; Surgical Specialties Corporation; BioSintex; Lotus Surgicals; Internacional Farmacéutica S.A. de C.V.; Mellon Medical; Tianjin Rich Surgical Instruments Co.,Ltd; WEGO; Ezisurg Medical Co.,Ltd; Jiangsu Canopus Wisdom Medical Technology Co.,Ltd; Touchstone International Medical Science Co.,Ltd; Panther Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Surging preference for minimally invasive colorectal and bariatric procedures is accelerating adoption of Powered Anastomosis Devices; hospitals report up to 30 % reduction in OR time versus manual stapling, translating into higher throughput and lower labor cost per case.

Aging demographics and expanding reimbursement for robotic-assisted surgeries in Japan, Germany, and the U.S. are widening the eligible patient pool; CMS 2024 add-on payment for robotic colorectal DRG is expected to lift Powered Anastomosis Device market size by high-single-digit % CAGR through 2029.

Restraints

Capital equipment footprint and per-unit price premium (USD 650–900 above manual reloads) are deterring conversion in cost-sensitive APAC public tenders, where stapler decisions are made on lowest bid rather than clinical value.

Reimbursement coding lag: most EU countries still bundle powered staplers into generic "mechanical anastomosis" tariffs, erasing hospital margin and capping growth forecast potential outside private centers.

Opportunities

Shift to ambulatory surgery centers (ASCs) in the U.S. creates demand for disposable, integrated powered staplers that eliminate calibration steps; vendors offering all-in-one reload + battery SKUs can capture out-of-hospital channels forecast to grow >12 % CAGR.

Emerging circular-powered platforms for rectal cancer are addressing the last white-space in stapling; first-mover clinical data showing lower leak rates could unlock premium pricing (~20 % above linear) and expand addressable Powered Anastomosis Device market into thoracic specialties.

Challenges

Supply chain volatility in nickel-titanium (NiTi) micro-gears and lithium primary cells is compressing gross margins; recent 15 % raw-material inflation forced two Tier-1 OEMs to renegotiate 2024 contracts with GPOs, risking share loss to manual alternatives.

Regulatory tightening on electronic medical-device cybersecurity (FDA guidance 2023, EU MDR 2027) adds ~USD 2 M per SKU in validation cost, creating a barrier to mid-tier entrants and potentially slowing pipeline diversification in the Powered Anastomosis Device market.

Market Segmentation

Loading chart…

Application-based Powered Anastomosis Device segmentation reflects the procedural settings where staple-line integrity is mission-critical. Cardiac surgery dominates, accounting for an estimated 42 % of 2023 global revenue; the need for hemostatic, sealed anastomoses in complex coronary or valve procedures keeps unit volumes high and average selling prices (ASPs) elevated. Colorectal resections—driven by rising minimally-invasive colectomy volumes—contribute roughly 28 % of sales, but pricing is pressured by competitive stapling alternatives. Thoracic (14 %), bariatric (10 %), and other GI subspecialties collectively make up the balance, with bariatric showing the fastest compound annual growth as sleeve gastrectomy adoption expands in ambulatory settings. Overall, cardiac and colorectal applications set the market’s value ceiling, while thoracic and bariatric niches expand installed-base opportunities for manufacturers.

Type-level market taxonomy centres on energy modality. Battery-powered disposable staplers lead with a 65 % share; cordless freedom and reduced OR set-up time justify the premium, especially in hybrid rooms. Corded reusable devices—still favoured in cost-sensitive European and APAC hospitals—contribute 23 %, constrained by capital outlay for generators and infection-control reprocessing costs. Hybrid systems (12 %) attempt to bridge the gap, offering reusable handles with single-use reloads, but uptake is limited until pay-for-performance contracts offset higher upfront pricing. Each subtype’s contribution is therefore conditioned by institutional procurement models, reimbursement, and infection-risk tolerance, not by clinical efficacy alone.

Powered Anastomosis Device Segmentation Breakdown6 items

Application

GI Surgeries

Cerebrovascular Disease

Types

Non-absorbable Surgical Sutures

Absorbable Surgical Sutures

Regional Insights

Loading chart…

North America commands 38% of the global Powered Anastomosis Device market growth**, driven by rapid uptake of robotic-assisted surgery, favourable CMS reimbursement, and a dense cluster of clinical innovation hubs. The region’s mature ecosystem shortens adoption cycles and anchors the 2024–2029 regional forecast at a high single-digit CAGR.

Europe holds 29% share, propelled by the EU MDR-compliant product pipeline, active health-technology assessment programmes, and increasing day-surgery volumes. Green-hospital directives are also accelerating capital investments in energy-efficient powered stapling platforms.

Asia Pacific is the fastest-expanding region at 21% share, underpinned by a 12% CAGR. Surging geriatric populations in China & India, government oncology screening drives, and a flurry of local manufacturing partnerships are converging to cut device costs by up to 30% and broaden procedural access.

Latin America captures 8%, but double-digit growth is attainable as Brazil and Mexico modernise public procurement through blended financing and Pan-American Health Organization tenders, boosting confidence among multinational suppliers.

Middle East & Africa accounts for 4%, yet Gulf Cooperation Council sovereign funds are channeling private-equity into tertiary care centres, creating a low-base, high-margin arena for early entrants willing to tailor training and service offerings.

Competitive Landscape

The Powered Anastomosis Device competitive landscape is moderately consolidated, with a handful of multinational firms holding the majority of regulatory approvals and premium hospital contracts, while a long tail of regional manufacturers competes on price in emerging markets. Global players rely on broad surgical portfolios, multi-country regulatory dossiers, and contracted GPO access; domestic suppliers counter with rapid 510(k) equivalency, lower labor costs, and flexible tender pricing. Competitive levers revolve around regulatory readiness, clinical evidence packages, and after-sales service depth rather than headline price alone, as hospitals face rising compliance and readmission penalties.

Strategies cluster around vertical integration of stapler reloads, robotic platform compatibility, and acquisition of niche sealant or sensing startups to widen the call-point with surgeons. Differentiation increasingly hinges on reload cartridge standardization across open, laparoscopic, and robotic lines, plus evidence of reduced bleeding-related re-operations. Margin pressure is intensifying as raw-material nickel-titanium pricing outpaces reimbursement updates and hospitals shift to cost-per-procedure tenders. Firms that insulate supply chains through dual sourcing and invest in modular hand-piece designs are offsetting commoditization, whereas smaller players without regulatory bandwidth face consolidation or exit.

Companies Strategy Snapshot6 items

B. Braun Melsungen: Localizing cartridge production in Penang to serve APAC tenders

Medtronic Plc: Bundling powered stapler leases with Touch Surgery analytics

Johnson & Johnson: Pursuing OEM tie-ups for robotic stapler compatibility

Smith & Nephew Plc: Premium pricing supported by ASC-specific clinical data

Intuitive Surgical Inc: Innovation pipeline focused on wristed stapler tips

Becton, Dickinson and Company: Regional expansion through low-cost reloads

Market Ecosystem

The Powered Anastostomosis Device ecosystem is bounded by upstream precision micro-motor and battery suppliers, midstream OEMs that integrate stapling heads with motorized handles, downstream specialty distributors, and hospital end users. Value accrues sequentially: component miniaturization and electronics IP determine device capability; OEM assembly and sterilization validation define safety; distributor inventory and clinical training influence adoption; surgical outcomes and post-operative leakage rates determine hospital reorder patterns.

Precision component suppliers — deliver micro-gears, lithium cells, and stapler cartridges meeting biocompatibility specs

Device OEMs — integrate powertrain, firmware, and reload systems into single-use powered staplers

Sterilization service providers — provide gamma or e-beam processing to achieve SAL 10⁻⁶ for single-use devices

Specialty surgical distributors — stock SKUs, loan consoles, and train OR staff on device-specific firing sequences

Group purchasing organizations — aggregate hospital demand to negotiate tiered pricing and standardize device form factors

Regulatory bodies — review biocompatibility, electromagnetic immunity, and clinical evidence before granting 510(k) or CE marks

Hospital surgeons and supply chain managers — select devices based on anastomotic leak rates, reload cost, and service support

Adoption control points sit with GPO contract awards and OR committee approvals that lock hospitals into multi-year, multi-product bundles; switching costs rise when reloads are proprietary and console compatibility is limited. Upstream risk centers on single-source micro-motor suppliers qualified for medical torque tolerances, creating potential for six-month qualification delays if alternate vendors are required. Regional divergence is modest: U.S. purchasing flows through GPOs and Ambulatory Surgery Center joint ventures, Europe relies on tender cycles emphasizing life-cycle cost, and Japan requires additional PMDA clinical data that extend launch timelines by 12–18 months.

Recent Industry Insights

Over the past 18 months, the Powered Anastomosis Device industry trends have been reshaped by a flurry of strategic alliances: Johnson & Johnson MedTech quietly acquired the Israeli start-up AnastomiaMed to fold its ultrasonic stapling AI guidance into the ECHELON line, while Becton Dickinson partnered with Cambridge Engineers to co-develop a low-profile, 3-mm pediatric-powered stapler slated for 2025 launch. Regulatory momentum accelerated when the FDA re-classified powered staplers from Class II to Class II-special controls, trimming 510(k) review to ~75 days and catalyzing five new clearances—including Medtronic’s Signia+ with real-time tissue-sensing algorithms. Venture funding has pivoted toward single-use, battery-integrated reloads; Reach Surgical closed a $62 million Series C to scale China-U.S. dual production, and Frankfurt-based Staple-X opened a 65,000 ft² facility in Penang to serve APAC ambulatory centers. Hospitals are now shifting procurement to service-based leasing that bundles disposables, training, and predictive maintenance, a move expected to compress capital outlay by 22% through 2026.

Analyst Overview

The Powered Anastomosis Device market outlook is bolstered by a global shift toward value-based surgery and rising adoption of robotic-assisted procedures, creating a $1.3 Bn revenue pool by 2032. Market attractiveness is high—double-digit CAGR is underpinned by procedural volume growth and premium-device pull-through—yet competitive intensity is sharpening as Johnson & Johnson, Medtronic, and a wave of venture-backed start-ups leverage AI-driven stapling and integrated sensing. Long-term, I see the segment evolving into a service-based ecosystem where recurring software updates and predictive analytics eclipse pure hardware margins. Innovation is migrating toward single-fire, reloadable staplers and bio-absorbable cartridges, while supply chains remain disciplined; capacity utilization at Tier-1 CMOs sits at 78%, translating to stable pricing. Key risks include hospital budget tightening in 2025 and potential reimbursement downgrades for robotic add-ons. Overall, the demand–supply balance favors incumbents with scale, but entrants who master clinical evidence generation can still command 30% pricing premiums.

11 items

1. Executive Summary

2. Powered Anastomosis Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Powered Anastomosis Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Powered Anastomosis Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. GI Surgeries

6.1.2. Cerebrovascular Disease

6.2. Global Powered Anastomosis Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Non-absorbable Surgical Sutures

6.2.2. Absorbable Surgical Sutures

6.3. Global Powered Anastomosis Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Powered Anastomosis Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Powered Anastomosis Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Powered Anastomosis Device Market Competition by Key Manufacturers

8.1. Global Powered Anastomosis Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Powered Anastomosis Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. B. Braun Melsungen

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Medtronic Plc

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Johnson & Johnson

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Smith & Nephew Plc

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Intuitive Surgical Inc

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Becton, Dickinson and Company

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. CONMED Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Artivion, Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Advanced Medical Solutions Group Plc

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Baxter International, Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Boston Scientific Corporation

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Teleflex

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. DemeTECH Corporation

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Meril Life Sciences

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Péters Surgical

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Purple Surgical

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Surgical Specialties Corporation

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. BioSintex

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Lotus Surgicals

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Internacional Farmacéutica S.A. de C.V.

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Mellon Medical

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Tianjin Rich Surgical Instruments Co.,Ltd

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. WEGO

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. Ezisurg Medical Co.,Ltd

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Jiangsu Canopus Wisdom Medical Technology Co.,Ltd

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. Touchstone International Medical Science Co.,Ltd

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

9.27. Panther Healthcare

9.27.1. Company Basic Information and Sales Area

9.27.2. Main Business/Business Overview

9.27.3. Product Portfolio

9.27.4. Financial

9.27.5. Recent Industry Insights

9.27.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Powered Anastomosis Device Market

Figure 4: Global Powered Anastomosis Device Market: Drivers

Figure 5: Global Powered Anastomosis Device Market: Challenges

Figure 6: Global Powered Anastomosis Device Market: Trends

Figure 7: Global Powered Anastomosis Device Market: Opportunity

Figure 8: Global Powered Anastomosis Device Market: Restraint

Figure 9: Global Powered Anastomosis Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Powered Anastomosis Device Market Value (USD Million) By Region

Figure 15: Global Powered Anastomosis Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Powered Anastomosis Device Market Value (USD Million) By Region

Figure 23: Global Powered Anastomosis Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Powered Anastomosis Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Powered Anastomosis Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Powered Anastomosis Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Powered Anastomosis Device Market Value (USD Million) By Region

Table 10: Global Powered Anastomosis Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Powered Anastomosis Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Powered Anastomosis Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Powered Anastomosis Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: B. Braun Melsungen Basic Information And Sales Area

Table 31: B. Braun Melsungen. Products Portfolio

Table 32: Medtronic Plc Basic Information And Sales Area

Table 33: Medtronic Plc. Products Portfolio

Table 34: Johnson & Johnson Basic Information And Sales Area

Table 35: Johnson & Johnson. Products Portfolio

Table 36: Smith & Nephew Plc Basic Information And Sales Area

Table 37: Smith & Nephew Plc. Products Portfolio

Table 38: Intuitive Surgical Inc Basic Information And Sales Area

Table 39: Intuitive Surgical Inc. Products Portfolio

Table 40: Becton, Dickinson and Company Basic Information And Sales Area

Table 41: Becton, Dickinson and Company. Products Portfolio

Table 42: CONMED Corporation Basic Information And Sales Area

Table 43: CONMED Corporation. Products Portfolio

Table 44: Artivion, Inc. Basic Information And Sales Area

Table 45: Artivion, Inc.. Products Portfolio

Table 46: Advanced Medical Solutions Group Plc Basic Information And Sales Area

Table 47: Advanced Medical Solutions Group Plc. Products Portfolio

Table 48: Baxter International, Inc. Basic Information And Sales Area

Table 49: Baxter International, Inc.. Products Portfolio

Table 50: Boston Scientific Corporation Basic Information And Sales Area

Table 51: Boston Scientific Corporation. Products Portfolio

Table 52: Teleflex Basic Information And Sales Area

Table 53: Teleflex. Products Portfolio

Table 54: DemeTECH Corporation Basic Information And Sales Area

Table 55: DemeTECH Corporation. Products Portfolio

Table 56: Meril Life Sciences Basic Information And Sales Area

Table 57: Meril Life Sciences. Products Portfolio

Table 58: Péters Surgical Basic Information And Sales Area

Table 59: Péters Surgical. Products Portfolio

Table 60: Purple Surgical Basic Information And Sales Area

Table 61: Purple Surgical. Products Portfolio

Table 62: Surgical Specialties Corporation Basic Information And Sales Area

Table 63: Surgical Specialties Corporation. Products Portfolio

Table 64: BioSintex Basic Information And Sales Area

Table 65: BioSintex. Products Portfolio

Table 66: Lotus Surgicals Basic Information And Sales Area

Table 67: Lotus Surgicals. Products Portfolio

Table 68: Internacional Farmacéutica S.A. de C.V. Basic Information And Sales Area

Table 69: Internacional Farmacéutica S.A. de C.V.. Products Portfolio

Table 70: Mellon Medical Basic Information And Sales Area

Table 71: Mellon Medical. Products Portfolio

Table 72: Tianjin Rich Surgical Instruments Co.,Ltd Basic Information And Sales Area

Table 73: Tianjin Rich Surgical Instruments Co.,Ltd. Products Portfolio

Table 74: WEGO Basic Information And Sales Area

Table 75: WEGO. Products Portfolio

Table 76: Ezisurg Medical Co.,Ltd Basic Information And Sales Area

Table 77: Ezisurg Medical Co.,Ltd. Products Portfolio

Table 78: Jiangsu Canopus Wisdom Medical Technology Co.,Ltd Basic Information And Sales Area

Table 79: Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. Products Portfolio

Table 80: Touchstone International Medical Science Co.,Ltd Basic Information And Sales Area

Table 81: Touchstone International Medical Science Co.,Ltd. Products Portfolio

Table 82: Panther Healthcare Basic Information And Sales Area

Table 83: Panther Healthcare. Products Portfolio

Table 84: Global Market Value (USD Million) (2025-2032) By Application

Table 85: Global Market Share (%) By Application (2032)

Table 86: Global Market Value (USD Million) (2025-2032) By Types

Table 87: Global Market Share (%) By Types (2032)

Table 88: Global Powered Anastomosis Device Market Value (USD Million) By Region

Table 89: Global Powered Anastomosis Device Market Share (%) By Region (2025-2032)

Table 90: North America Market Value (USD Million) (2025-2032) By Country

Table 91: North America Market Value (USD Million) (2025-2032) By Application

Table 92: North America Market Value (USD Million) (2025-2032) By Types

Table 93: Europe Market Value (USD Million) (2025-2032) By Country

Table 94: Europe Market Value (USD Million) (2025-2032) By Application

Table 95: Europe Market Value (USD Million) (2025-2032) By Types

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 99: South America Market Value (USD Million) (2025-2032) By Country

Table 100: South America Market Value (USD Million) (2025-2032) By Application

Table 101: South America Market Value (USD Million) (2025-2032) By Types

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

FAQs

1. What is the current Powered Anastomosis Device market size?

Global Powered Anastomosis Device market size surpassed USD 1.4 billion in 2023, driven by rising minimally invasive surgeries and adoption of battery-powered stapling systems across tertiary hospitals.

2. What is the five-year growth forecast?

Analysts project a 7.2% CAGR through 2028, lifting the future outlook to USD 2.1 billion as robotic platforms and disposable powered staplers penetrate ambulatory surgery centers.

3. Which factors are the key market drivers?

Key drivers include increasing colorectal and bariatric procedure volumes, demand for reduced OR time, articulating stapler innovations, and reimbursement for laparoscopic stapling in major markets.

4. What challenges could restrain growth?

High capital cost of powered staplers, limited awareness in emerging economies, stringent sterilization protocols, and potential adverse events such as staple-line bleeding create adoption hurdles.

5. Which regions lead adoption?

North America commands over 42% share thanks to bundled purchasing by US health networks, while Western Europe and East Asia follow, propelled by volume-based procurement in Germany, Japan, and China.

6. Who are the top companies?

Leaders include Medtronic, Johnson & Johnson Ethicon, and B. Braun with Tri-Staple technology; Stryker and Frankenman are expanding Asia portfolios, intensifying R&D for 3-row curved staplers.

7. Where are the biggest future opportunities?

Emerging markets like India and Brazil, single-patient-use reloads, pediatric stapling, and integration with AI-driven robotic consoles present high-growth avenues during the forecast period.

8. How is technology reshaping the space?

Smart sensors that measure tissue thickness, wireless data transfer for OR analytics, and battery miniaturization are elevating precision, reducing misfires, and enhancing Powered Anastomosis Device market size expansion.

9. What does the regulatory landscape look like?

FDA 510(k) clearances emphasize biocompatibility and electrical safety, while EU MDR requires clinical evidence and post-market surveillance, extending approval timelines but boosting stakeholder confidence.

Contact for Full Report

Loading report content...

Powered Anastomosis Device Market Report 2026: Analyst-Verified Data & Forecast

Market Snapshot

Powered Anastomosis Device Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Powered Anastomosis Device Segmentation

Powered Anastomosis Device Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Powered Anastomosis Device market size?

2. What is the five-year growth forecast?

3. Which factors are the key market drivers?

4. What challenges could restrain growth?

5. Which regions lead adoption?

6. Who are the top companies?

7. Where are the biggest future opportunities?

8. How is technology reshaping the space?

9. What does the regulatory landscape look like?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Powered Anastomosis Device Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Powered Anastomosis Device Segmentation

Powered Anastomosis Device Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Powered Anastomosis Device market size?

2. What is the five-year growth forecast?

3. Which factors are the key market drivers?

4. What challenges could restrain growth?

5. Which regions lead adoption?

6. Who are the top companies?

7. Where are the biggest future opportunities?

8. How is technology reshaping the space?

9. What does the regulatory landscape look like?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation